🔎 Trials Near Me

Hjem › Alfa-1-antitrypsinmangel › Arizona

Kliniske studier for Alfa-1-antitrypsinmangel i Arizona

3 studier for Alfa-1-antitrypsinmangel søker deltakere på steder i Arizona.

Byer i Arizona

Offisiell studietekst (engelsk)

A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

  • GC2501 Study Site 102, Phoenix
  • GC2501 Study Site 107, Scottsdale
RekruttererFase 3
Alder 18 til 80 · Alle kjønn · Oppdatert 11. aug. 2026 · NCT07555483

Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein

  • St. Joseph's Hospital and Medical Center, Phoenix
  • Mayo Clinic, Phoenix
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 13. mai 2026 · NCT05677971

Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)

  • St Joseph's Hospital and Medical Center, Phoenix
  • Mayo Clinic - PPDS, Phoenix
  • University of Arizona Thomas D. Boyer Liver Institute, Tucson
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 5. mar. 2026 · NCT06165341

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.